Vascular endothelial cell growth factor-a: not just for endothelial cells anymore.
作者信息
D'Amore Patricia A
机构信息
Schepens Eye Institute, Department of Ophthalmology & Pathology, Boston, MA 02114, USA.
出版信息
Am J Pathol. 2007 Jul;171(1):14-8. doi: 10.2353/ajpath.2007.070385.
Abstract
摘要
相似文献
1
Vascular endothelial cell growth factor-a: not just for endothelial cells anymore.
Am J Pathol. 2007 Jul;171(1):14-8. doi: 10.2353/ajpath.2007.070385.
2
[Safety aspect of age macular degeneration treatment].
Vestn Oftalmol. 2012 Jul-Aug;128(4):75-7.
3
Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
Vascul Pharmacol. 2010 Jan-Feb;52(1-2):84-94. doi: 10.1016/j.vph.2009.12.002. Epub 2009 Dec 16.
4
Radiation therapy for neovascular age-related macular degeneration revisited.
Br J Ophthalmol. 2009 Mar;93(3):279-80. doi: 10.1136/bjo.2008.153296.
5
A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1315-24. doi: 10.1161/ATVBAHA.109.201327. Epub 2010 Apr 22.
6
Vascular endothelial growth factor.
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):789-91. doi: 10.1161/ATVBAHA.108.179663. Epub 2009 Jan 22.
7
A new treatment for ocular neovascularization.
N Engl J Med. 2004 Dec 30;351(27):2863-5. doi: 10.1056/NEJMe048316.
8
VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
Br J Ophthalmol. 2008 Jun;92(6):839-43. doi: 10.1136/bjo.2007.135640. Epub 2008 May 29.
9
Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin.
J Neurochem. 2012 Mar;120(5):818-29. doi: 10.1111/j.1471-4159.2011.07622.x. Epub 2012 Jan 23.
10
The expression of growth factors and their receptors in retinal and endothelial cells cocultured in the rotating bioreactor.
Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-44-50.
引用本文的文献
1
Multifaceted Role of Notch Signaling in Vascular Health and Diseases.
Biomedicines. 2025 Mar 31;13(4):837. doi: 10.3390/biomedicines13040837.
2
Effect of Parenchymal Arachnoid on Brain Fluid Transport.
Basic Clin Neurosci. 2024 Mar-Apr;15(2):221-232. doi: 10.32598/bcn.2022.3089.1. Epub 2024 Mar 1.
3
Therapeutic Effects of Anti-Inflammatory and Anti-Oxidant Nutritional Supplementation in Retinal Ischemic Diseases.
Int J Mol Sci. 2024 May 18;25(10):5503. doi: 10.3390/ijms25105503.
4
sFlt-1 in Chronic Kidney Disease: Friend or Foe?
Int J Mol Sci. 2022 Nov 16;23(22):14187. doi: 10.3390/ijms232214187.
5
New Insights into Treating Early and Advanced Stage Diabetic Retinopathy.
Int J Mol Sci. 2022 Jul 31;23(15):8513. doi: 10.3390/ijms23158513.
6
Differential Effects of Cytopathic Hypoxia on Human Retinal Endothelial Cellular Behavior: Implication for Ischemic Retinopathies.
Int J Mol Sci. 2022 Apr 12;23(8):4274. doi: 10.3390/ijms23084274.
7
Effects of shear stress on differentiation of stem cells into endothelial cells.
World J Stem Cells. 2021 Jul 26;13(7):894-913. doi: 10.4252/wjsc.v13.i7.894.
8
Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FDA adverse event reporting system.
Transl Lung Cancer Res. 2021 Jun;10(6):2614-2624. doi: 10.21037/tlcr-21-464.
9
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.
Eye (Lond). 2020 Jun;34(Suppl 1):1-51. doi: 10.1038/s41433-020-0961-6.
10
A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion.
Medicine (Baltimore). 2020 May 22;99(21):e20222. doi: 10.1097/MD.0000000000020222.
本文引用的文献
1
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.
Am J Pathol. 2007 Jul;171(1):53-67. doi: 10.2353/ajpath.2007.061237.
2
A very effective treatment for neovascular macular degeneration.
N Engl J Med. 2006 Oct 5;355(14):1493-5. doi: 10.1056/NEJMe068191.
3
Ranibizumab for neovascular age-related macular degeneration.
N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481.
4
VEGF expression and receptor activation in the choroid during development and in the adult.
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3135-42. doi: 10.1167/iovs.05-1229.
5
Soluble endoglin contributes to the pathogenesis of preeclampsia.
Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038/nm1429. Epub 2006 Jun 4.
6
Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential.
Neurosignals. 2005;14(5):207-21. doi: 10.1159/000088637.
7
Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function.
Am J Pathol. 2005 Nov;167(5):1451-9. doi: 10.1016/S0002-9440(10)61231-X.
8
Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.
Hypertension. 2005 Nov;46(5):1077-85. doi: 10.1161/01.HYP.0000187899.34379.b0. Epub 2005 Oct 17.
9
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.
Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H560-76. doi: 10.1152/ajpheart.00133.2005. Epub 2005 Sep 19.
10
Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling.
Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H547-59. doi: 10.1152/ajpheart.00616.2005. Epub 2005 Sep 19.
Zotero 插件